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a  b  s  t  r  a  c  t
Propionibacterium  acnes  has been  detected  in  diseased  human  prostate  tissue,  and  cell  culture  exper-
iments  suggest  that the  bacterium  can  establish  a low-grade  inﬂammation.  Here,  we investigated  its
impact  on  human  primary  prostate  epithelial  cells.  Microarray  analysis  conﬁrmed  the  inﬂammation-
inducing  capability  of  P. acnes  but also  showed  deregulation  of  genes  involved  in  the  cell cycle.  qPCR
experiments  showed  that  viable  P. acnes  downregulates  a  master  regulator  of  cell cycle  progression,
FOXM1.  Flow  cytometry  experiments  revealed  that P. acnes  increases  the  number  of  cells  in S-phase.
We  tested  the  hypothesis  that  a P.  acnes-produced  berninamycin-like  thiopeptide  is  responsible  for  thisell cycle
OXM1
erninamycin
hiopeptide
effect,  since  it is  related  to  the  FOXM1  inhibitor  siomycin.  The  thiopeptide  biosynthesis  gene  cluster
was  strongly  expressed;  it  is  present  in  subtype  IB  of P. acnes,  but  absent  from  type  IA, which  is most
abundant  on  human  skin.  A knock-out  mutant  lacking  the  gene  encoding  the  berninamycin-like  peptide
precursor  was  unable  to downregulate  FOXM1  and  to halt  the  cell cycle.  Our study  reveals  a novel  host
cell-interacting  activity  of  P.  acnes.
© 2016  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CC. Introduction
Propionibacteria can be found as part of the skin microbiota on
lmost every human being. In particular, P. acnes successfully and
ften exclusively colonizes sebaceous follicles of the face and back.
n the last decade, improved microbial cultivation approaches,
enome sequencing, phylotyping efforts, host-bacterium interac-
ion studies, and animal experiments have revealed that P. acnes
an act as an opportunistic pathogen (Brüggemann et al., 2004;
rzuszkiewicz et al., 2011; Fitz-Gibbon et al., 2013; Kistowska
Abbreviations: IL, interleukin; EPCAM, epithelial cell adhesion molecule; PrEC,
rimary prostate epithelial cells; CFU, colony forming unit; IPA, Ingenuity Pathway
nalysis; DAVID, Database for Annotation Visualization and Integrated Discov-
ry; MOI, multiplicity of infection; p.i., post infection; PLK1, Polo-like kinase 1;
CNB1, Cyclin B1; CENPF, Centromere protein F; APC, anaphase-promoting com-
lex/cyclosome.
 Microarray data from this publication has been deposited in NCBI’s Gene Expres-
ion Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are accessible through
EO Series accession number GSE72585. Reviewer access link: http://www.ncbi.
lm.nih.gov/geo/query/acc.cgi?token=ihaloakcjdmrjal&acc=GSE72585.
∗ Corresponding author at: Max  Planck Institute for Infection Biology, Charitéplatz
,  10117 Berlin, Germany.
E-mail address: meyer@mpiib-berlin.mpg.de (T.F. Meyer).
ttp://dx.doi.org/10.1016/j.ijmm.2016.06.006
438-4221/© 2016 The Authors. Published by Elsevier GmbH. This is an open access artic
.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
et al., 2014; Lomholt and Kilian, 2010; McDowell et al., 2012, 2013;
Olsson et al., 2012; Perry and Lambert, 2011; Shinohara et al., 2013).
At the same time, new ﬁndings regarding the possible beneﬁcial
role of P. acnes for the host have been made, and the microbial
interactions with the host immune system have been highlighted
(Agak et al., 2014; Belkaid and Segre, 2014; Kistowska et al., 2014,
2015; Qin et al., 2014). Apart from its association with the highly
prevalent skin disorder acne vulgaris, there is accumulating evi-
dence for a role of P. acnes in the pathogenesis at non-skin sites, e.g.
with respect to postoperative and device-related infections, includ-
ing those of joint prostheses, shunts and prosthetic heart valves.
Circumstantial evidence exists for a role in cases of endocarditis,
post-neurosurgical central nervous system infections, dental infec-
tions, bacterial endophthalmitis, postoperative spine infections and
sarcoidosis (Eishi, 2013; Perry and Lambert, 2011).
Another association concerns prostate pathologies: several
studies reported the isolation and cultivation of P. acnes from rad-
ical prostatectomy specimens, and its visualization in cancerous
tissue (Alexeyev et al., 2007; Bae et al., 2014; Cohen et al., 2005;
Fassi Fehri et al., 2011). In vitro experiments showed that P. acnes
triggered the secretion of cytokines and chemokines such as inter-
leukin (IL)-6, IL-8 and GM-CSF in RWPE-1 cells, a prostate epithelial
cell line that was  immortalized with human papillomavirus 18
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
5  of Me
(
t
t
e
s
t
I
b
F
t
g
c
a
n
b
v
u
o
i
t
p
d
a
v
2
2
A
s
I
u
c
(
m
a
m
d
2
w
m
f
r
c
K
a
c
a
w
a
a
2
w
S
E
I
t18 B. Sayanjali et al. / International Journal
Bae et al., 2014; Drott et al., 2010; Fassi Fehri et al., 2011). In
hese cells, P. acnes induced a delayed but sustained inﬂamma-
ion, which was associated with prolonged NF-B activation (Mak
t al., 2012). Moreover, infection with P. acnes modulates adhe-
ion and proliferation properties of RWPE-1 cells, which results in
he initiation of cellular transformation (Fassi Fehri et al., 2011).
mmunoﬂuorescence and electron microscopy has demonstrated
acterial invasion and intracellular persistence of P. acnes (Fassi
ehri et al., 2011; Mak  et al., 2012). In animal experiments the bac-
erium was able to induce a persistent infection of the prostate
land (Olsson et al., 2012; Shinohara et al., 2013). Despite this cir-
umstantial evidence, the role of P. acnes in prostate pathologies is
 matter of controversy. It is possible that the pathogen might colo-
ize the anaerobic zones of an existing prostate tumor and/or might
e introduced during surgery or during previous surgical inter-
ention, since patients who undergo radical prostatectomy usually
ndergo multiple biopsy procedures beforehand.
Here, we wanted to investigate the host response to exposure
f P. acnes in a primary prostate cell model that mimics a possible
n vivo encounter with P. acnes more accurately than an immor-
alized cell culture model. We  found that P. acnes can act as a
ro-inﬂammatory stimulus as well as a cell cycle disrupter. Evi-
ence for a possible mechanism for cell cycle interference involving
 P. acnes-produced thiopeptide is presented and the in vivo rele-
ance of our ﬁndings is discussed.
. Material and methods
.1. Antibodies
Polyclonal anti-P. acnes antibody 1:100 (Fassi Fehri et al., 2011),
nti-EPCAM (Epithelial cell adhesion molecule) (1:200, BD Bio-
ciences), Anti-E-cadherin (1:200, BD Biosciences), and anti-rabbit
gG secondary antibody (1:150, Jackson ImmunoResearch) were
sed for immunoﬂuorescence analysis. For immunoblotting, poly-
lonal rabbit antibodies against Aurora B/AIM1, PLK1 and CCNB1
1:1000, Cell Signaling), FOXM1 (K-19 Santa Cruz, 1:1000), mouse
onoclonal anti-p53 (DO-1, Santa Cruz, 1:500) and monoclonal
nti-B-actin antibody (1:5000, Sigma-Aldrich) were used. Anti-
ouse and anti-rabbit secondary antibodies (Amersham) were
iluted 1:2000 for western blotting.
.2. Cell culture and bacteria
Human primary prostate epithelial cells (PrEC, Lonza, CC-2555)
ere cultured in PrEGM complete medium (CC-3166) supple-
ented with bovine pituitary extract (BPE), epidermal growth
actor, insulin, hydrocortisone, retinoic acid, transferrin, triiodothy-
onine and epinephrine, at 37 ◦C in a humidiﬁed incubator
ontaining 5% CO2. Three P. acnes wild type strains were used,
PA171202 (type IB; DSMZ, no. 16379) (Brüggemann et al., 2004) P.
cnes strain P6 (type IB, strain collection no. X524), an isolate from a
ancerous prostate (Fassi Fehri et al., 2011; Mak  et al., 2013) and P.
cnes strain 266 (type IA) (Brzuszkiewicz et al., 2011). All strains
ere cultured on Brucella agar plates for 4 days at 37 ◦C under
naerobic conditions. For heat inactivation, P. acnes was  incubated
t 60 ◦C for 30 min.
.3. Mutagenesis of P. acnes
The thiopeptide knockout mutant (strain collection no. X551)
as generated as described previously (Sörensen et al., 2010).
train P. acnes KPA171202 was used as the wild-type strain and
scherichia coli DH5 was used as a recipient in all cloning steps.
n brief, a 583 bp upstream and a 547 bp downstream region of
he thiopeptide precursor encoding gene (berA1) were ampliﬁeddical Microbiology 306 (2016) 517–528
using the primer combinations Thio 1/Thio 2 and Thio 3/Thio 4,
respectively (Supplementary Table 2). The fragments were gel-
puriﬁed, digested with Acc65I and ligated. After column puriﬁcation
of the ligation mixture (QIAquick, Qiagen) a PCR was  carried out
using the ligation mixture as a template with the primer combi-
nation Thio 1/Thio 4. The approx. 1 kb product was gel-puriﬁed
and cloned into pGEM-T-easy. Positive E. coli DH5 clones were
obtained and isolated plasmids were tested for the correct insert
by restriction digestion. Plasmid DNA was  subsequently digested
with Acc65I and ligated with the Acc65I-digested fragment con-
taining the erythromycin-resistance cassette; This fragment was
ampliﬁed using genomic DNA of Saccharopolyspora erythraea (DSM
no. 40517) as a template using the primers ermE for and ermE rev.
The ligation mixture was  transformed into E. coli DH5. Ampicillin
(100 g/ml)-resistant clones were obtained. Prior to electropora-
tion into P. acnes KPA171202, plasmid DNA was extracted from
positive clones and transformed into the dam-negative E. coli strain
GM2199. Competent cells of P. acnes KPA171202 were prepared as
described previously (Sörensen et al., 2010). Electrocompetent P.
acnes cells were freshly prepared before the electroporation, which
was carried out using a Gene Pulser (BioRad) and 0.1 cm electropo-
ration cuvettes. Plasmid DNA (6 g; isolated from the dam-negative
E. coli strain GM2199) was added to 50 l competent P. acnes cells.
Gene Pulser settings of 50 F, 400 ,  and 1.5 kV were used. Subse-
quently, cells were recovered in 1 ml  pre-warmed BHI medium,
and centrifuged (5 min, 3000g). The resulting pellet was resus-
pended in 100 l BHI medium and plated out on a Brucella agar
plate without any antibiotics. The plate was  incubated for 24 h at
37 ◦C under anaerobic conditions. The following day, bacteria were
harvested using a sterile cotton swab, resuspended and washed in
pre-warmed BHI medium and re-plated on Brucella plates contain-
ing 10 g/ml erythromycin, and incubated for 4–6 days. All clones
obtained were tested by PCR to validate the correct knock-out of
the thiopeptide precursor encoding gene.
2.4. RNA preparation and RNA-seq
Total RNA from P. acnes (strain KPA171202) grown under anaer-
obic conditions to the exponential and stationary growth phase in
BHI medium at 37 ◦C was  prepared with the RNA PowerSoil®Total
RNA Isolation Kit (Mo-Bio, USA), following manufacturer instruc-
tions. RNA quality was controlled using the Bioanalyzer (Agilent
Technologies, USA).
The cDNA libraries were constructed by Vertis Biotechnology
AG, Germany, as previously described (Dugar et al., 2013; Sharma
et al., 2010). The cDNA libraries were sequenced using a HiSeq 2000
machine (Illumina) in single-read mode and 100 cycles. Detailed
descriptions of procedures used for quality control, read mapping,
expression graph construction and normalization of expression
graphs have been published previously (Dugar et al., 2013). For
graph visualization the Integrative Genome Browser (IGB version
8.5.4) was used (Nicol et al., 2009).
2.5. Infection of prostate epithelial cells
P. acnes wild-type and mutant strains were harvested from Bru-
cella plates, washed in the respective cell culture medium and
diluted. Viability of bacteria was  assessed by colony-forming unit
(CFU) counts; CFU counts ascertained that P. acnes was viable in the
cell culture medium used over the indicated infection time peri-
ods. PrEC cells were seeded into six-well plates. Cells were infected
48 h later with P. acnes strains at MOI  100 for short-term infections
(24 h and 48 h) and MOI  30 for long-term infection (2 weeks) in a
humidiﬁed 5% CO2 atmosphere at 37 ◦C. For long-term infection
the medium was replaced every 48 h and the cells were passaged
after one week.
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.6. Host cell viability
A WST-1 assay (WST-1 Cell Proliferation Kit, Abcam) was  used
o determine host cell viability in the absence and presence of
. acnes. The assay measures the activity of cellular mitochondrial
ehydrogenases that can cleave the tetrazolium salt WST-1 to
ormazan. Formazan formation was quantiﬁed by measuring the
hange in absorbance at 440 nm in a microplate reader (procedure
s described by the manufacturer).
.7. Antibiotic protection assay
Bacterial entry into host cells was quantiﬁed by antibiotic pro-
ection assay. Cells were seeded in 24-well plates prior to infection.
t 24 h p.i., tetracycline (Sigma-Aldrich) was added for 2 h at a
nal concentration of 50 M/ml  to kill the extracellular bacteria.
ells were washed and 1% saponin (Sigma) was added to perme-
bilize cells, followed by plating of appropriate dilutions of lysate
n Brucella agar. Assays were performed in duplicate wells. Each
xperiment was repeated at least three times.
.8. Protein extraction, SDS-PAGE and western blotting
Cells grown in six-well plates were washed with PBS and lysed
n Laemmli buffer containing protease inhibitor cocktail (cOmplete,
oche). Samples were boiled at 95 ◦C for 10 min  and stored at
20 ◦C until required. Proteins were separated on 12% SDS-PAGE
nd then transferred to polyvinylidene diﬂuoride (PVDF) mem-
ranes (PerkinElmer Life Sciences). The PVDF-membranes were
locked in 3% non-fat dry milk tris-buffered saline (containing 0.5%
ween 20) for 30 min. Membranes were probed with primary anti-
odies and HRP-conjugated secondary antibodies, and detected
ith ECL reagent (Amersham). ECL Western blotting substrate was
etected by Hyperﬁlm ECL (Amersham Biosciences). The mono-
lonal anti-B-actin antibody (Sigma) was used as a loading control.
ll blots shown are representative of at least three independent
xperiments.
.9. Microarray and transcriptome analysis
Microarray experiments were performed as dual-color
ybridizations. To compensate for dye-speciﬁc effects, a dye-
eversal color swap was applied (Churchill, 2002). Samples were
solated with TRIzol (Invitrogen) and total RNA was  prepared
ccording to manufacturer’s instructions using glycogen as a
arrier. The amount and purity of total RNA was assessed using an
gilent 2100 bioanalyzer (Agilent Technologies) and a NanoDrop
000 spectrophotometer (Kisker). RNA labeling was  performed
ith the Quick Amp Labeling Kit (Agilent Technologies). In brief,
RNA was reverse-transcribed and ampliﬁed using an oligo-dT-
7-promotor primer, and resulting cDNA was labeled with either
yanine 3-CTP or Cyanine 5-CTP. After precipitation, puriﬁcation,
nd quantiﬁcation, 1.25 g of each labeled cDNA was fragmented
nd subsequently hybridized to whole-human genome 44k
icroarrays (AMADID-014850 and Agilent-026652), according to
he manufacturer’s protocol (Agilent Technologies). Hybridized
icroarrays were washed using the SSC washing protocol (Agilent
echnologies). Scanning of microarrays was performed with 5 m
esolution and using extended dynamic range (XDR) using a DNA
icroarray laser scanner (Agilent Technologies). Raw microar-
ay image data were analyzed with the Image Analysis/Feature
xtraction software G2567AA (Version A.11.5.1.1, Agilent). The
xtracted MAGE-ML ﬁles were further analyzed with the Rosetta
esolver Biosoftware, Build 7.2. Ratio proﬁles comprising single
ybridizations were combined in an error-weighted fashion to
reate ratio experiments. A 2-fold change expression cut-off fordical Microbiology 306 (2016) 517–528 519
ratio experiments was applied together with anti-correlation of
ratio proﬁles rendering the microarray analysis highly signiﬁcant
(p-value < 0.01), robust and reproducible. The data presented in
this publication have been deposited in NCBI’s Gene Expression
Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are acces-
sible through GEO Series accession number GSE72585. Ingenuity
Pathway Analysis (IPA; http://www.ingenuity.com) software
was used for functional analyses of transcriptome data. The tool
identiﬁed the biological functions and/or diseases that were most
signiﬁcant to the expression data. Genes which were de-regulated
at least two  fold with p-values < 0.01 were included in the analysis
and associated with biological functions and/or diseases in the
Ingenuity Knowledge Base. Right-tailed Fisher’s exact test was
used to calculate a p-value determining the probability that each
biological function and/or disease assigned to data sets was  due
to chance alone. DAVID (The Database for Annotation, Visual-
ization and Integrated Discovery) was also used as a functional
annotation tool which helps identify the biological meaning in
large datasets (https://david.ncifcrf.gov/). For the identiﬁcation
of protein–protein interactions String was used (http://string-
db.org/). Only genes which were deregulated at least 2-fold with
p-values < 0.01 were analyzed.
2.10. Quantitative PCR
We evaluated the expression pattern of FOXM1 and its cell cycle-
related targets before and after infection by RT-PCR. Total RNA was
extracted from infected and uninfected cells using TRIzol accord-
ing to manufacturer’s protocol. After DNAse-treatment (Invitrogen)
and Bioanalyzer quality control (Agilent Technologies), the result-
ing RNA was used for RT-PCR validation. Reactions were prepared
according to the manufacturer’s protocol using SYBR Green PCR
Master Mix  (Applied Biosystems) and cycled on a 7900HT Real-
Time PCR System (Applied Biosystems). GAPDH was used as an
internal control and all reactions were run in triplicate. mRNA lev-
els were quantiﬁed by calculating average 2−Ct values, where
Ct is the cycle number for the control and target transcript at the
chosen threshold. Ct = Cttarget − CtGAPDH was  calculated by sub-
tracting the average Ct of GAPDH from the average Ct of the target
transcript. The relative difference in expression between infected
and uninfected cells was  calculated as fold change. All the primers
used for this study were designed using the NCBI BLAST tool and
are listed in Supplementary Table 2. These primers were designed
to speciﬁcally detect all the possible isoforms of the target genes.
2.11. Immunoﬂuorescence microscopy
PrEC cells were grown on autoclaved 12-mm cover slips. After
P. acnes infection, cells were washed with PBS and ﬁxed with 4%
paraformaldehyde in PBS for 15 min  at room temperature followed
by three washes in PBS/0.1% Tween-20. Cells were stained by per-
meabilizing with 0.2% Triton X-100 for 15 min  and blocking with
3% bovine serum albumin (BSA, Biomol) in PBS for 30 min, all at
room temperature. Primary antibody against P. acnes was  used at
1:100 dilution for 1 h, followed by a detection step using Cy2 or Cy3-
conjugated anti-rabbit IgG secondary antibodies (1:150, 1 h). Nuclei
were stained with Draq5 (Cell Signaling). Cover slips were mounted
in Mowiol and analyzed by confocal laser scanning microscopy
using a Leica TCS SP equipped with an argon–krypton mixed gas
laser. Images were taken using appropriate excitation and emis-
sion ﬁlters for the ﬂuorescence dyes used. Overlay images of the
single channels were obtained using Adobe Photoshop.Extra-/intracellular staining was achieved as follows: after ﬁx-
ation of infected cells with 4% paraformaldehyde and blocking
with 3% BSA for 30 min, extracellular bacteria were stained with
primary anti-P. acnes antibody for 1 h and subsequently detected
520 B. Sayanjali et al. / International Journal of Medical Microbiology 306 (2016) 517–528
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tig. 1. Invasion of P. acnes into PrEC cells. Immunoﬂuorescence experiments were ca
nfections were performed with an MOI  of 100 for 24 h. Green: extracellular P. acne
f  three independent experiments are shown.
ith secondary Cy2-conjugated anti mouse IgG antibody (1:150,
 h; Jackson ImmunoResearch). Cells were then permeabilized with
.2% Triton X-100 for 15 min  and intracellular bacteria were stained
ith primary anti-P. acnes antibody for 1 h, and detected with
econdary Cy3-conjugated anti-mouse IgG antibody (1:150, 1 h;
ackson Immunoresearch). Coverslips were mounted in Mowiol
nd analyzed.
.12. Flow cytometry analysis
Cell cycle analysis using ﬂow cytometry was performed by
NA content as published (Pozarowski and Darzynkiewicz, 2004).
rieﬂy, PrEC cells were cultured in PrEGM medium and synchro-
ized using serum starvation. Before infection with P. acnes the
edium was replaced with medium containing serum and the
nfection was performed as described above. Once semi conﬂuent,
ells were detached using trypsin and ﬁxed with 100% EtOH. Fixed
ells were washed with cold PBS and DNA was stained with pro-
idium iodide (PI, Life Technologies). Cells were then re-suspended
n RSA-PI(50) buffer (PBS supplemented with 100 g/ml RNaseA,
% fetal bovine serum, 0.02% NaN3 and 50 g/ml PI), and analyzed
y ﬂuorescent ﬂow cytometer LSRII cell analyzer. PI signal can be
etected at 617 nm,  at FL2 channel for FACSCalibur. The percentage
f cells in each gate was then normalized against the total number
f cells in each sample.
.13. Statistical analysisThe results are represented as means ± SD.  p-values for deter-
ining statistical signiﬁcance were calculated using an unpaired
wo-tailed Student’s t-test.out with double-staining of P. acnes to distinguish intra- from extracellular bacteria.
 intracellular P. acnes, Blue; cellular nuclei. Scale bar 50 m. Representative images
3. Results
3.1. Establishment of the PrEC cell infection model
We  ﬁrst set up a new infection model using human primary
prostate epithelial cells known as PrEC cells (Sobel et al., 2006).
A primary model is better suited to mimic  the in vivo scenario of
prostate tissue exposure to P. acnes compared to the immortalized
cancer-like cell lines used previously (Fassi Fehri et al., 2011; Olsson
et al., 2012). PrEC cells were checked for expression of the epithelial
cell markers EpCAM and E-cadherin, conﬁrming that the primary
culture did not contain any contaminating mesenchymal cells (data
not shown). PrEC cells were infected with a clinical P. acnes prostate
isolate (strain P6, type IB) at different multiplicities of infection
(MOIs) and for different time points (MOI 100 for 24 and 48 h; MOI
30 for 2 weeks). Similar to previous in vitro infection models (Drott
et al., 2010; Fassi Fehri et al., 2011; Mak  et al., 2012) invasion of P.
acnes could also be observed in PrEC cells, as judged from antibiotic
protection assays and immunoﬂuorescence microscopy of double-
stained extra- and intracellular P. acnes (Fig. 1, Supplementary Fig.
1A). We  conﬁrmed that cell viability was not adversely affected by
P. acnes infection at the time points tested (Supplementary Fig. 1B).
3.2. Transcriptional proﬁles of P. acnes-infected PrEC cells
We  decided to ﬁrst monitor the global transcriptional response
of PrEC cells to P. acnes P6 infection (MOI 100). The genome-
wide transcriptional proﬁles at 24 h post infection (p.i.) and at
48 h p.i. were determined using microarray technology. Our anal-
ysis focused on genes that were differentially expressed between
infected and non-infected cells. At 24 h p.i. a total of 1517 genes
were differentially expressed with a minimum fold-change of 2.5
(674 and 843 genes were down- or upregulated after infection,
B. Sayanjali et al. / International Journal of Medical Microbiology 306 (2016) 517–528 521
Fig. 2. Functional analyses of the genome-wide transcriptional response in P. acnes-infected PrEC cells. (A) Functional analysis of deregulated genes in PrEC cells upon P.
acnes  infection, performed with Ingenuity Pathway Analysis (IPA). P-values indicate signiﬁcance of enrichment of cellular/molecular functions in the transcriptome at 24 h
p.i.  P-value threshold was  set to 5.0E-6. Results show that the function “Cell cycle” was the most highly enriched function. All deregulated cell cycle-related genes were
down-regulated. (B) IPA network analysis of deregulated genes in P. acnes-infected PrEC cells revealed one highly signiﬁcant network (p-value 3.2E-13) that centers around
a  master regulator of cell cycle progression, FOXM1. (C) Direct targets of the FOXM1 transcription factor network involved in the G2/M transition of mitotic cell cycle were
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-fold  downregulation is indicated with a dotted line. Representative results of thre
espectively) (Supplementary Table 1A). At 48 h p.i. a total of 1100
enes were differentially expressed with a minimum fold-change
f 2 (528 and 572 genes were down- or upregulated after infec-
ion, respectively) (Supplementary Table 1B). Pathway analyses of
eregulated genes were carried out with the tools DAVID, STRING
nd Ingenuity pathway analysis (IPA). The most signiﬁcant enriched
ellular function among all deregulated genes at 24 h and 48 h p.i
as cell cycle (DAVID p-values 6.7E-8 and 1.6E-6, respectively)
Fig. 2A). 32 and 24 genes assigned to cell cycle were downreg-
lated at 24 h and 48 h p.i., respectively (Supplementary Fig. 2A).
oreover, a String analysis showed that 50 downregulated genes
re involved in kinetochore and centromere functionality, includ-
ng key genes such as NDC80, NUF2, SPC25, CDC20, CENPA and
ENPF (Supplementary Fig. 2B), suggesting a disturbance of the
ell cycle after P. acnes infection. Among the upregulated genes,
he most enriched KEGG pathway was cytokine–cytokine receptor
nteraction (p-values 1.0E-5 and 3.3E-2 at 24 h and 48 h p.i, respec-
ively), as well as functionally related pathways (Toll-like receptor
ignaling, chemokine signaling) (data not shown). The most upreg-nregulation). (D) RT-PCR validated targets; transcript levels of the listed genes in
ost of its targets were strongly downregulated. RB1 was used as a negative control.
ependent experiments are shown.
ulated cytokines and chemokines were IL-1 members, IL6, IL8, CCL5,
CXCL5, CXCl10, CXCL11 and CXCL14 (Supplementary Table 1). Apart
from the deregulation of cell cycle-relevant genes, the data is com-
parable with previous work that showed that P. acnes can induce
inﬂammatory processes in different host cells (Drott et al., 2010;
Fassi Fehri et al., 2011; Grange et al., 2009; Mak  et al., 2012). Apart
from the short term infection, a 2-week infection of PrEC cells also
resulted in very similar ﬁndings regarding the deregulation of cell
cycle genes (Supplementary Table 1C, Supplementary Fig. 2C), indi-
cating a persistent rather than a transient impact of P. acnes on the
cell cycle.
3.3. P. acnes infection downregulates a master regulator of cell
cycle progression, FOXM1, and its target genesThe impact of P. acnes on the transcription of cell cycle genes in
PrEC cells prompted us to look into more detail. Pathway analyses
revealed that many of the downregulated genes including Aurora
B kinase (AURKB), Polo-like kinase 1 (PLK1), Cyclin B1 (CCNB1) and
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nduced a signiﬁcant increase of cells in S-phase compared to non-infected or thiope
n  the G0/G1 and G2/M phases. Representative results of three independent experim
entromere protein F (CENPF) are known to be controlled by the key
egulator FOXM1, which plays a crucial role in cell proliferation and
ell cycle progression (Costa, 2005; Laoukili et al., 2005; Wierstra,
013a) (Fig. 2B and C). In agreement, FOXM1 expression was  also
ownregulated after P. acnes infection (2.6-, 3- and 2.3-fold at 24 h,
8 h and 2 weeks p.i, respectively) (Supplementary Table 1). We
urther validated and conﬁrmed the downregulation of FOXM1 and
ts direct targets in cell culture experiments using RT-PCR: FOXM1
ranscription was  4–5 fold downregulated in P. acnes-infected PrEC
ells (Fig. 2D). A known FOXM1 inhibitor, siomycin A, was used
s a positive control (Gartel, 2013); at a concentration of 20 M
t downregulated FOXM1 transcription and protein expression in
rEC cells similar to P. acnes infection (Supplementary Fig. 3A and
).
.4. P. acnes induces cell cycle alterations in PrEC cells
To investigate the consequences of FOXM1 downregulation,
ow cytometry analyses with propidium iodide-stained cells were
erformed to determine the impact of P. acnes on cell cycle progres-
ion in PrEC cells. DNA contents of synchronized infected cells were
ompared to those of non-infected cells at 24 h p.i. Exposure of cells
o P. acnes led to a statistically signiﬁcant increase in the number of analysis with propidium iodide-stained synchronized cells was performed. P. acnes
deletion mutant-infected cells at 24 h p.i. No signiﬁcant differences were detectable
 are shown.
cells in S-phase (Fig. 3). While 11.9% (±2.6%) of non-infected cells
were in S-phase, this increased to 16.5% (±4.1%) upon P. acnes infec-
tion at 24 h p.i. (p < 0.05; unpaired t-test). No signiﬁcant differences
were detectable in the G0/G1 and G2/M phases. This shows that P.
acnes infection leads to a cell cycle disturbance in PrEC cells.
3.5. A thiopeptide gene cluster encoding a berninamycin A-like
precursor is present in the genome of P. acnes P6 and other type
IB strains
The thiopeptide siomycin A (produced by Streptomyces sioyaen-
sis)  was used as a positive control. This molecule, produced as a
precursor peptide that is heavily post-translationally modiﬁed, has
previously been shown to inhibit FOXM1, in addition to its func-
tion as a macrocyclic antibiotic with selective antibacterial activity
against several Gram-negative and Gram-positive bacteria (Gartel,
2010, 2013; Tanaka et al., 1970). Interestingly, previous studies
reported that some P. acnes genomes contain a gene cluster that
encodes the biosynthesis of a thiopeptide with similarity to the
thiopeptide biosynthesis pathway of Streptomyces species, in par-
ticular to siomycin A and berninamycin A biosynthesis; the latter
thiopeptide is produced by Streptomyces bernensis (Brzuszkiewicz
et al., 2011; Malcolmson et al., 2013). We  searched the genome of
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Fig. 4. Thiopeptide encoding genomic region. (A) Schematic representation of the thiopeptide biosynthesis-encoding gene clusters in P. acnes (strain KPA171202) and S.
bernensis.  In P. acnes, the gene cluster encodes 10 genes (PPA0859-PPA0866 and two  berA genes), including homologs of berABCDEG from S. bernensis. The two precursor
peptides are encoded by berA1 and berA2;  the genes are located up- and downstream of the putative gene PPA0866. (B) BerA1 of P. acnes possesses an almost identical copy
of  the 16-aa structural core peptide (in red) of berninamycin A from S. bernensis. BerA2 of P. acnes is more distantly related. (C) Comparison of the genomic region containing
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ghe  thiopeptide gene cluster in ﬁve P. acnes strains. The thiopeptide biosynthesis 
ere:  strains KPA171202, 6609, and P6), but absent in type IA strains (shown here: 
lignment was  done with Sybil (http://sybil.sourceforge.net/).
. acnes strain P6 (GenBank accession number ARZZ00000000) and
ound an identical thiopeptide biosynthesis gene cluster to the one
escribed in P. acnes KPA171202 (Fig. 4A). The gene cluster in strains
6 and KPA171202 (both type IB strains) harbors two genes (here
esignated berA1 and berA2) that encode two different thiopep-
ide precursors. The one encoded by berA1 is almost identical to
he precursor peptide of berninamycin A, with the exception of a
erine residue at the C-terminus (Fig. 4B).
Further analysis revealed that the thiopeptide biosynthesis gene
luster is present in the genomes of all tested type IB P. acnes
trains, but it is absent from the genomes of strains belonging to
ype IA (Fig. 4C). It was reported that type IB strains have a higher
ntimicrobial activity against Staphylococcus epidermidis isolates
ompared with other types of P. acnes (Christensen et al., 2016). This
ould indicate that the thiopeptide produced by type IB strains has
ntimicrobial activity, in analogy to the main functions of siomycin
 and berninamycin A of Streptomyces species.
.6. Expression proﬁle of thiopeptide biosynthesis genes in P.
cnes
Characterization of the thiopeptide of P. acnes requires its iso-
ation. However, all efforts to isolate the thiopeptide from P. acnes
ith HPLC-mass spectrometry approaches were unsuccessful, indi-
ating that it is either not produced or labile. Instead, RNA-seq was
sed to investigate the expression of the thiopeptide biosynthesis
ene cluster. This revealed that the whole cluster is expressed in thecluster (PPA0859 to PPA0866, boxed in blue) is present in type IB strains (shown
s 12.1.L1 and 266). Please note that the genome of strain P6 is not closed. The gene
exponential as well as stationary growth phases (Fig. 5). Strikingly,
the highest transcription is associated with berA1. In contrast, berA2
was not transcribed, indicating that berA1 is the only functional
thiopeptide precursor-encoding gene in P. acnes, at least under
the growth conditions applied. Interestingly, berA1 contains a long
untranslated region (5′-UTR) that could have a regulatory function.
3.7. Berninamycin A is able to inhibit FOXM1 in PrEC cells, similar
to P. acnes infection
Due to the unavailability of the P. acnes thiopeptide, and since
BerA1 of P. acnes is almost 100% identical to the berninamycin A pre-
cursor peptide from S. bernensis, we  decided to use berninamycin
A for subsequent experiments. Since siomycin A and berninamycin
A are similar, we hypothesized that berninamycin A is also able
to inhibit FOXM1. qPCR showed that berninamycin A treatment of
PrEC cells at a ﬁnal concentration of 20 M could indeed down-
regulate the transcription of FOXM1 (Fig. 6A). In addition, Western
blotting experiments revealed a reduction of FOXM1 protein lev-
els in berninamycin A-treated PrEC cells compared to non-treated
cells (Fig. 6B). Furthermore, the protein levels of the FOXM1 targets
AURKB, PLK1 and CCNB1 were also strongly reduced in berni-
namycin A-treated cells, at levels comparable to the reduction
observed in P. acnes infected cells. This suggests that a berni-
namycin A-like molecule produced by P. acnes could be responsible
for the drastic effect on FOXM1 and the cell cycle in PrEC cells.
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Fig. 5. Strong expression of berA1, but not berA2 within the thiopeptide biosynthesis gene cluster of P. acnes. RNA-seq was applied to record the expression of the thiopeptide
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Tiosynthesis pathway-encoding gene cluster (PPA0859 to PPA0866) in P. acnes (stra
xpressed the gene cluster. The most strongly expressed gene was the thiopeptide 
5′-UTR). In contrast, berA2 was not transcribed under the growth conditions appli
.8. Infection of PrEC cells with a thiopeptide deletion mutant
oes not alter FOXM1 expression and cell cycle progression
A berA1 knockout strain was constructed in P. acnes
PA171202 (type IB), the only P. acnes strain we have so far been
ble to genetically modify (Sörensen et al., 2010). First, we con-
rmed that strains KPA171202 and P6 had the same effect on
OXM1 on gene and protein level (Supplementary Fig. 4A and B).
e then tested whether mutant and wild-type strains had com-
arable infection properties in PrEC cells. An antibiotic protection
ssay showed no signiﬁcant change in the ability to invade PrEC
ells between wild-type and mutant strains, suggesting that the
eletion had no effect on the infection capability of P. acnes (Supple-
entary Table 3). In addition, cell viability was found to be the same
n PrEC cells infected with the mutant or wild-type strain (Supple-
entary Fig. 1B). Subsequent qPCR experiments showed that the
utant, unlike the wild-type strain, was not able to downregulate
OXM1 and selected targets (Fig. 6A). This was also observed on
rotein level: FOXM1, AURKB, PLK1 and CCNB1 protein levels were
ot reduced in cells infected with the mutant strain (Fig. 6B). In
greement, ﬂow cytometry analysis revealed that the mutant, in
ontrast to the wild-type strain, was unable to change the number
f cells in S-phase compared to non-infected cells (Fig. 3). Taken
ogether, these results suggest that a berninamycin A-like thiopep-
ide produced by P. acnes is able to inhibit FOXM1 and alter cell
ycle progression.
In a further experiment we used a different strain, P. acnes
66, belonging to the phylogroup IA. Genome analyses determined
hat strain 266, like other type IA strains, does not contain the
hiopeptide-encoding gene cluster (Fig. 4C). Infections with strain
66 showed similar rates of bacterial invasion into PrEC cells, as
bserved with the other tested P. acnes strains (Supplementary
able 3). qPCR experiments showed that strain 266 had only a171202). Bacteria grown to exponential (EXP) and stationary (STAT) growth phases
rsor-encoding gene berA1 (see zoom-in), that possesses a long untranslated region
moderate effect on FOXM1, which was  downregulated <2 fold (Sup-
plementary Fig. 4C).
4. Discussion
Our study investigated the response of primary human prostate
cells to P. acnes. We  focused on the ability of P. acnes to alter the cell
cycle progression in PrEC cells. Interestingly, the analysis of down-
regulated genes identiﬁed many FOXM1 targets that play crucial
roles in cell proliferation and cell cycle progression. Among them,
we found a large network of cell cycle relevant genes that have spe-
ciﬁc structural or regulatory roles in kinetochore and centromere
assembly and functionality. To our knowledge, this has not previ-
ously been described for any other bacterium-host cell interaction.
Our results showed a P. acnes-dependent accumulation of PrEC cells
in S-phase, without any apparent effect on cell viability. In this
context, the location of P. acnes within the host cell is intriguing.
Our previous studies have shown that P. acnes accumulates intra-
cellularly in close proximity to the nuclear envelope in epithelial
prostate cells (RWPE1) (Fassi Fehri et al., 2011; Mak  et al., 2012).
This location may thus turn out to be important for the bacterial
impact on the cell cycle. In future experiments we will investigate
if invasiveness is a prerequisite for cell cycle alterations in PrEC cells
and other cell culture models.
Several other bacteria have been reported to interfere with
cell cycle progression in their respective host cells. Staphylococ-
cus aureus is able to induce a G2/M transition phase delay in HeLa
cells (Alekseeva et al., 2013). Shigella was shown to cause cell cycle
arrest in HeLa cells by targeting Mad2L2, an anaphase-promoting
complex/cyclosome (APC) inhibitor (Iwai et al., 2007), and Neisse-
ria meningitidis causes cell cycle arrest of human brain endothelial
cells at S-phase (Oosthuysen et al., 2015). Host cell cycle perturba-
tion was also observed upon infections with Listeria monocytogenes
and Helicobacter pylori (Fehri et al., 2009; Leitao et al., 2014). In
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Fig. 6. A thiopeptide deletion mutant of P. acnes does not alter transcript and protein levels of FOXM1 and its targets in PrEC cells. (A) RT-PCR for FOXM1 mRNA and its
direct  targets was  carried out in PrEC cells treated with berninamycin A (20 M)  or infected for 24 h with P. acnes wild-type (strain KPA171202) and the thiopeptide-deletion
mutant strain (Mu). Transcript levels of the listed genes are downregulated in berninamycin A-treated and in wild-type strain-infected, but not in mutant strain-infected
PrEC  cells. Infection had no effect on expression of RB1. A 5-fold downregulation is marked with a dotted line. Three independent experiments were performed. (B) P. acnes
wild-type strain infection, as well as treatment of cells with 20 M berninamycin A for 24 h inhibits the production of FOXM1, AURKB, PLK1 and CCNB1 in infected PrEC cells,
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argets  in PrEC cells. Protein levels of p53 were not altered in wild-type or mutant-in
xperiments are shown.
ost studies the exact mechanisms by which bacteria interfere
ith the cell cycle are not known. Regarding the biological signiﬁ-
ance, it has been suggested that pathogen-induced host cell cycle
lteration serves the pathogen to better colonize and propagate,
or instance by delaying epithelial renewal or reducing host cell
efense functions (Alekseeva et al., 2013; Iwai et al., 2007).Our study indicates that P. acnes has a distinct mechanism to
lter the cell cycle, i.e.,  by inhibiting FOXM1 in a thiopeptide-
ependent manner. Thiopeptides, also called thiazolyl peptides, thiopeptide deletion mutant did not reduce protein levels of FOXM1 and its tested
d compared to non-infected PrEC cells. Representative results of three independent
have multiple functions; in addition to their innate antibacterial
activity, they can for example have anti-cancer, anti-plasmodial
and immunosuppressive activities. Thiostrepton and siomycin A
produced by Streptomyces species are known FOXM1 inhibitors
(Bhat et al., 2009; Gartel, 2013; Radhakrishnan et al., 2006) that
are able to down-regulate the transcriptional activity as well as the
protein and mRNA abundance of FOXM1 via proteasome inhibition.
Their major in vivo role is most likely as macrocyclic antibiotics with
potent and selective antibacterial activity against Gram-negative
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nd Gram-positive bacteria (Tanaka et al., 1970). Berninamycin A
roduced by S. bernensis is similar to siomycin A and has been
hown to act as an antibiotic too, thereby acting as a vigorous
nhibitor of protein synthesis in Gram-positive bacteria (Reusser,
969; Thompson et al., 1982).
We show here that in analogy to siomycin A, berninamycin A
an also act as a FOXM1 inhibitor. FOXM1 has diverse key roles
n eukaryotic cells including the regulation of many G2/M-speciﬁc
enes that are essential for chromosome stability. FOXM1 down-
egulation leads to pleiotropic cell cycle defects, including a delay in
2, chromosome mis-segregation and frequent failure of cytokine-
is (Wierstra, 2013a,b). For instance, FOXM1 activates transcription
f cyclin B, which is essential for a timely mitotic entry, whereas
ENP-F, another direct target of FOXM1, is essential for precise
unctioning of the mitotic spindle checkpoint (Costa, 2005). Thus,
y downregulating FOXM1 in PrEC cells, P. acnes is able to exert a
rofound effect on cell cycle progression, most likely due to pertur-
ations of kinetochore and centromere assembly and functionality.
The in vivo signiﬁcance of this study remains to be determined.
ssuming that the bacterium is encountering and invading primary
pithelial cells of human prostates, as suggested by previous studies
Alexeyev et al., 2007; Bae et al., 2014; Cohen et al., 2005; Fassi
ehri et al., 2011; Mak  et al., 2012, 2013; Shinohara et al., 2013),
e have to take two different responses and thus scenarios into
onsideration.
One response is triggered by the bacterium’s pro-inﬂammatory
ctivity on prostate epithelial cells (Drott et al., 2010; Fassi Fehri
t al., 2011; Mak  et al., 2012), resulting in the release of chemokines
nd cytokines, including IL-6. Previous work suggested that this
nﬂammatory response induces cell proliferation and anchorage-
ndependent growth of infected cells, thus supporting cellular
ransformation (Fassi Fehri et al., 2011). The outcome depends
n the severity and duration of the inﬂammation; some evi-
ence exists that P. acnes is able to establish a persistent infection
ather than a transient one (Mak  et al., 2012; Shinohara et al.,
013). Important for the outcome will also be the individual
ontributions of innate and adaptive immunity. Apart from the
ong-term secretion of inﬂammatory mediators during a persis-
ent infection, adaptive immunity is activated, potentially involving
. acnes-speciﬁc Th1 and Th17 responses, as seen in inﬂamed skin
Kistowska et al., 2015).
The second response, i.e. the impact of P. acnes on FOXM1 and the
ell cycle as outlined in this report, points towards an opposing con-
equence of a P. acnes infection. By blocking cell cycle progression,
ells might be silenced and eventually eliminated, thus reducing
he risk of cellular survival and proliferation and eventual transfor-
ation. In line with this, inhibition of FOXM1 and its targets have
een suggested as anti-tumor therapy (Briest et al., 2015; Jiang
t al., 2015; Miao et al., 2014). In this regard, it should be men-
ioned that P. acnes was used in anti-cancer therapies in the 70 s and
0 s of the last century (Halpern et al., 1966; Smith and Woodruff,
968). The anti-tumor activity has mainly been attributed to a P.
cnes-triggered Th1 response (Tsuda et al., 2011), but a more direct
acterial effect on the cellular fate may  be involved as well. Inter-
stingly, another study supported the assumption of a possible
nti-cancer effect of P. acnes: it was observed that higher anti-
. acnes antibody titers were inversely associated with prostate
ancer risk (Severi et al., 2010). Our study suggests that this sec-
nd, anti-cancer scenario of P. acnes is phylotype-dependent: only
hiopeptide-producing type IB strains would exert this effect on the
ell cycle, but not strains of type IA, the most abundant phylotype
n human skin. In this regard, type IA and IB strains have been dif-
erently associated with disease or health, respectively, and these
ypes induce different host cell responses (Fitz-Gibbon et al., 2013;
omholt and Kilian, 2010; Nagy et al., 2005; Rollason et al., 2013).
t remains to be seen if the thiopeptide-producing ability of P. acnesdical Microbiology 306 (2016) 517–528
type IB results in a host beneﬁcial effect or at least in reduced patho-
genesis. A recent study has investigated the phylotype distribution
of P. acnes strains isolated from cancerous prostates (100 cases):
Most strains belonged to type II (51%), followed by type IA (27%)
(Davidsson et al., 2016). Both types do not possess the thiopeptide
gene cluster. In contrast, only 15% of the isolate strains belonged to
type IB. This suggests that the majority of P. acnes strains present in
cancerous prostates do not possess the capability of thiopeptide-
mediated FOXM1 inhibition.
Elucidating the long-term fate of host cells following infection
with P. acnes will be a future focus of interest. Initial data suggest
that arrested cells do not undergo apoptosis. Instead, host cell fate
might be driven towards senescence. This is in accordance with
observations showing that FOXM1 prevents cellular senescence
and FOXM1 degradation leads to cellular senescence. Likewise,
downregulation of the FOXM1 targets PLK1 or SKP2 induces senes-
cence in primary cells (Kim et al., 2013; Lin et al., 2010). Since
inhibition of FOXM1 is currently discussed in anti-cancer therapy
(Bella et al., 2014; Halasi and Gartel, 2013), the identiﬁcation of new
inhibitors is of crucial interest. Our study introduces a promising
new FOXM1 inhibitor, provided that the P. acnes thiopeptide can
be puriﬁed to study its bioactivity in depth.
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